Second-generation kinase inhibitors

BM Klebl, G Müller - Expert opinion on therapeutic targets, 2005 - Taylor & Francis
An increasing number of kinase inhibitor candidates are entering clinical development,
representing an important change in the pharmaceutical industry; notably, the development …

Second-generation kinase inhibitors

BM Klebl, G Müller - Expert opinion on therapeutic targets, 2005 - pubmed.ncbi.nlm.nih.gov
An increasing number of kinase inhibitor candidates are entering clinical development,
representing an important change in the pharmaceutical industry; notably, the development …

Second-generation kinase inhibitors.

BM Klebl, G Müller - Expert Opinion on Therapeutic Targets, 2005 - europepmc.org
An increasing number of kinase inhibitor candidates are entering clinical development,
representing an important change in the pharmaceutical industry; notably, the development …